<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00004210</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000067459</org_study_id>
    <secondary_id>NCI-95-HG-0165</secondary_id>
    <secondary_id>NCI-NMOB-9501</secondary_id>
    <secondary_id>NHGRI-95-HG-0165</secondary_id>
    <nct_id>NCT00004210</nct_id>
    <nct_alias>NCT00001470</nct_alias>
  </id_info>
  <brief_title>Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer</brief_title>
  <official_title>Outcomes in Education and Counseling for HNPCC Testing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Human Genome Research Institute (NHGRI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Identifying family and individual characteristics may help plan education and&#xD;
      counseling for patients who are considering genetic testing.&#xD;
&#xD;
      PURPOSE: This clinical trial is studying education and counseling to see what effect they&#xD;
      have in patients who are undergoing genetic testing for hereditary nonpolyposis colon cancer&#xD;
      (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within&#xD;
      families already participating continues).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
        -  Identify family characteristics, personality traits, and religious and spiritual beliefs&#xD;
           that significantly affect individual decisions regarding mutation testing for hereditary&#xD;
           nonpolyposis colon cancer (HNPCC) (recruitment of new families with HNPCC stopped as of&#xD;
           04-26-06, recruitment of persons within families already participating continues).&#xD;
&#xD;
        -  Determine the impact of negative vs positive mutation test results on family&#xD;
           relationships and psychological status.&#xD;
&#xD;
        -  Assess expectations regarding testing and how they influence perceptions of risks and&#xD;
           responses to risk notification.&#xD;
&#xD;
        -  Determine the impact of risk notification on the frequency of screening/prevention&#xD;
           activities.&#xD;
&#xD;
        -  Formulate a standard diagnostic algorithm for determining microsatellite instability&#xD;
           based on the analysis of tumors with this extensive array of markers and correlate&#xD;
           specific replication error phenotypes with germline genotype.&#xD;
&#xD;
      OUTLINE: Participants complete a baseline assessment of knowledge, risk perception, and&#xD;
      personality traits followed by a structured pretest education session. Participants are then&#xD;
      offered the choice of whether or not to undergo genetic testing for mutations in hereditary&#xD;
      nonpolyposis colon cancer (HNPCC) genes. Participants who choose to undergo genetic testing&#xD;
      provide a blood sample for this purpose. Participants who undergo genetic testing receive&#xD;
      results and counseling (recruitment of new families with HNPCC stopped as of 04-26-06,&#xD;
      recruitment of persons within families already participating continues).&#xD;
&#xD;
      Available surveillance options are discussed for all participants. Psychological and&#xD;
      behavioral outcomes are reassessed at 6 and 12 months for both those choosing and not&#xD;
      choosing genetic testing.&#xD;
&#xD;
      Tumors (when available) are analyzed for mismatched repair deficiency on the basis of&#xD;
      microsatellite instability.&#xD;
&#xD;
      PROJECTED ACCRUAL: A total of 900 participants will be accrued for this study, with a&#xD;
      specific target of 200 individuals who have not experienced cancer within families identified&#xD;
      with hereditary nonpolyposis colon cancer (HNPCC) mutations (recruitment of new families with&#xD;
      HNPCC stopped as of 04-26-06, recruitment of persons within families already participating&#xD;
      continues).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2000</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of cancer risk perception, cancer screening practices, views regarding genetic services, and family communication about HNPCC / Lynch syndrome by family members</measure>
  </primary_outcome>
  <enrollment type="Actual">900</enrollment>
  <condition>Colorectal Cancer</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>loss of heterozygosity analysis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>microsatellite instability analysis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>mutation analysis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>counseling intervention</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Meets one of the following criteria:&#xD;
&#xD;
               -  Family history consistent with hereditary nonpolyposis colon cancer (HNPCC)*&#xD;
&#xD;
                    -  At least 3 relatives with histologically proven colorectal cancer or&#xD;
                       HNPCC-associated cancer and 1 is a first-degree relative of the other 2&#xD;
&#xD;
                    -  At least 2 successive generations affected&#xD;
&#xD;
                    -  Colorectal cancer (or HNPCC-associated cancer) diagnosed under age 50 in 1&#xD;
                       of the relatives&#xD;
&#xD;
               -  Diagnosis of colorectal cancer under age 41&#xD;
&#xD;
               -  HNPCC-associated cancer/polyps* under age 41 with a microsatellite instability&#xD;
                  (MSI) phenotype&#xD;
&#xD;
               -  Multiple primary HNPCC-associated cancers* regardless of family history&#xD;
&#xD;
               -  Colorectal or other HNPCC-associated tumor/polyp* demonstrating a positive MSI&#xD;
                  phenotype and at least 1 second-degree (or closer) and 1 third-degree (or closer)&#xD;
                  relative with a HNPCC-associated cancer&#xD;
&#xD;
                    -  1 affected family member must have one of the following:&#xD;
&#xD;
                         -  Right-sided colon cancer&#xD;
&#xD;
                         -  Multiple primary HNPCC-associated cancers&#xD;
&#xD;
                         -  Diagnosis of cancer prior to age 51 NOTE: *Recruitment of new families&#xD;
                            with HNPCC stopped as of 04-26-06, recruitment of persons within&#xD;
                            families already participating continues&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
        Age:&#xD;
&#xD;
          -  18 and over&#xD;
&#xD;
        Performance status:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Life expectancy:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Hematopoietic:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Hepatic:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Renal:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
        Biologic therapy:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Chemotherapy:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Endocrine:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Radiotherapy:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Surgery:&#xD;
&#xD;
          -  Not specified&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald W. Hadley, MS, CGC</last_name>
    <role>Study Chair</role>
    <affiliation>National Human Genome Research Institute (NHGRI)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892-1182</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Human Genome Research Institute</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892-4470</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Hadley DW, Ashida S, Jenkins JF, Calzone KA, Kirsch IR, Koehly LM. Colonoscopy use following mutation detection in Lynch syndrome: exploring a role for cancer screening in adaptation. Clin Genet. 2011 Apr;79(4):321-8. doi: 10.1111/j.1399-0004.2010.01622.x. Epub 2011 Jan 19.</citation>
    <PMID>21204803</PMID>
  </results_reference>
  <results_reference>
    <citation>Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2004 Jan 1;22(1):39-44. doi: 10.1200/JCO.2004.06.128.</citation>
    <PMID>14701766</PMID>
  </results_reference>
  <results_reference>
    <citation>Hadley DW, Jenkins J, Dimond E, Nakahara K, Grogan L, Liewehr DJ, Steinberg SM, Kirsch I. Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med. 2003 Mar 10;163(5):573-82. doi: 10.1001/archinte.163.5.573.</citation>
    <PMID>12622604</PMID>
  </results_reference>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>January 21, 2000</study_first_submitted>
  <study_first_submitted_qc>January 26, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2003</study_first_posted>
  <last_update_submitted>October 23, 2014</last_update_submitted>
  <last_update_submitted_qc>October 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>colon cancer</keyword>
  <keyword>rectal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

